• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液神经丝轻链和总tau 作为阿尔茨海默病和额颞叶痴呆神经退行性变的生物标志物。

Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia.

机构信息

Neurology Unit Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Memory Clinic Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Department of Neuroscience, Catholic University of the Sacred Heart, Rome, Italy.

Neurology Unit Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Memory Clinic Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Department of Neuroscience, Catholic University of the Sacred Heart, Rome, Italy.

出版信息

Neurobiol Dis. 2023 Oct 1;186:106267. doi: 10.1016/j.nbd.2023.106267. Epub 2023 Aug 29.

DOI:10.1016/j.nbd.2023.106267
PMID:37652185
Abstract

INTRODUCTION

CSF Neurofilament light chain(NfL) is a promising biomarker of neurodegeneration, but its utility in discriminating between Alzheimer's disease(AD) and frontotemporal dementia(FTD) is limited.

METHODS

105 patients with clinical-biological diagnosis of mild cognitive impairment(MCI) due to AD (N = 72) or clinical diagnosis of FTD (N = 33) underwent neuropsychological assessment and CSF Aβ42/40, p-tau181, total-tau and NfL quantification. Group comparisons, correlations between continuous variables and ROC curve analysis were carried out to assess NfL role in discriminating between MCI due to AD and FTD, exploring the associations between NfL, ATN biomarkers and neuropsychological measures.

RESULTS

NfL levels were significantly lower in the AD group, while levels of total-tau were higher. In the FTD group, significant correlations were found between NfL, p-tau181 and total-tau, and between NfL and cognitive performances. In the AD group, NfL levels were directly correlated with total-tau and p-tau181; Aβ42/40 ratio was inversely correlated with total-tau and p-tau181, but not with NfL. Moreover, p-tau181 and t-tau levels were found to be associated with episodic memory and lexical-semantic impairment. Total-tau/NfL ratio differentiated prodromal-AD from FTD with an AUC of 0.951, higher than the individual measures.

DISCUSSION & CONCLUSIONS: The results support that NfL and total-tau levels reflect distinct pathophysiological neurodegeneration mechanisms, independent and dependent of Aβ pathology, respectively, Combining them may enhance both markers reliability, their ratio showing high accuracy in distinguishing MCI due to AD from FTD. Moreover, our results revealed associations between NfL and disease severity in FTD and between tauopathy and episodic memory and lexical-semantic impairment in prodromal-AD.

摘要

简介

脑脊液神经丝轻链(NfL)是一种有前途的神经退行性疾病生物标志物,但在区分阿尔茨海默病(AD)和额颞叶痴呆(FTD)方面的效用有限。

方法

105 名临床生物学诊断为 AD 引起的轻度认知障碍(MCI)的患者(N=72)或临床诊断为 FTD 的患者(N=33)接受了神经心理学评估和 CSF Aβ42/40、p-tau181、总 tau 和 NfL 定量检测。进行组间比较、连续变量之间的相关性和 ROC 曲线分析,以评估 NfL 在区分 AD 引起的 MCI 和 FTD 中的作用,探索 NfL、ATN 生物标志物和神经心理学测量之间的关联。

结果

AD 组的 NfL 水平显著降低,而总 tau 水平升高。在 FTD 组中,NfL 与 p-tau181 和总 tau 之间,以及 NfL 与认知表现之间存在显著相关性。在 AD 组中,NfL 水平与总 tau 和 p-tau181 呈直接相关;Aβ42/40 比值与总 tau 和 p-tau181 呈负相关,但与 NfL 无关。此外,p-tau181 和 t-tau 水平与情景记忆和词汇语义障碍有关。总 tau/NfL 比值区分了前驱期 AD 和 FTD,AUC 为 0.951,高于单个指标。

讨论与结论

结果支持 NfL 和总 tau 水平反映了不同的神经退行性病理生理学机制,分别独立于和依赖于 Aβ 病理学。将它们结合起来可以提高两种标志物的可靠性,它们的比值在区分 AD 引起的 MCI 和 FTD 方面具有很高的准确性。此外,我们的结果揭示了 FTD 中 NfL 与疾病严重程度之间的关系,以及前驱期 AD 中 tau 病变与情景记忆和词汇语义障碍之间的关系。

相似文献

1
Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia.脑脊液神经丝轻链和总tau 作为阿尔茨海默病和额颞叶痴呆神经退行性变的生物标志物。
Neurobiol Dis. 2023 Oct 1;186:106267. doi: 10.1016/j.nbd.2023.106267. Epub 2023 Aug 29.
2
Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias.血浆 p-tau181、NfL 和 GFAP 在现患神经退行性痴呆临床队列中的诊断价值。
Alzheimers Res Ther. 2022 Oct 12;14(1):153. doi: 10.1186/s13195-022-01093-6.
3
Diagnostic Performance and Clinical Applicability of Blood-Based Biomarkers in a Prospective Memory Clinic Cohort.基于血液的生物标志物在前瞻性记忆临床队列中的诊断性能和临床适用性。
Neurology. 2023 Feb 21;100(8):e860-e873. doi: 10.1212/WNL.0000000000201597. Epub 2022 Nov 30.
4
Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.额颞叶痴呆谱系患者的脑脊液生物标志物:一项单中心研究。
J Alzheimers Dis. 2018;66(2):551-563. doi: 10.3233/JAD-180409.
5
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression.血浆神经丝轻链和磷酸化 tau181 作为阿尔茨海默病病理和临床疾病进展的生物标志物。
Alzheimers Res Ther. 2021 Mar 25;13(1):65. doi: 10.1186/s13195-021-00805-8.
6
Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.阿尔茨海默病连续体中的血浆 Aβ42/40 比值、p-tau181、GFAP 和 NfL:AIBL 队列的横断面和纵向研究。
Alzheimers Dement. 2023 Apr;19(4):1117-1134. doi: 10.1002/alz.12724. Epub 2022 Jul 21.
7
Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy.路易体痴呆、阿尔茨海默病、额颞叶痴呆和进行性核上性麻痹中神经退行性变血浆生物标志物的差异水平。
J Neurol Neurosurg Psychiatry. 2022 Jun;93(6):651-658. doi: 10.1136/jnnp-2021-327788. Epub 2022 Jan 25.
8
Serum neurofilament light chain as a surrogate of cognitive decline in sporadic and familial frontotemporal dementia.血清神经丝轻链作为散发性和家族性额颞叶痴呆认知下降的替代标志物。
Eur J Neurol. 2022 Jan;29(1):36-46. doi: 10.1111/ene.15058. Epub 2021 Sep 3.
9
Blood Neurofilament Light Chain in Different Types of Dementia.不同类型痴呆症中的血液神经丝轻链。
Curr Alzheimer Res. 2023;20(3):149-160. doi: 10.2174/1567205020666230601123123.
10
A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias.神经丝轻链、神经胶质纤维酸性蛋白和神经元五聚素-2 的联合检测可区分额颞叶痴呆和其他类型痴呆。
J Alzheimers Dis. 2022;90(1):363-380. doi: 10.3233/JAD-220318.

引用本文的文献

1
Serum neurofilament light protein as a biomarker in Niemann-Pick disease, type C1.血清神经丝轻链蛋白作为C1型尼曼-匹克病的生物标志物。
Genet Med Open. 2025 Jul 7;3:103443. doi: 10.1016/j.gimo.2025.103443. eCollection 2025.
2
Radiomics feature similarity: A novel approach for characterizing brain network changes in patients with behavioral variant frontotemporal dementia.放射组学特征相似性:一种表征行为变异型额颞叶痴呆患者脑网络变化的新方法。
Neuroimage Clin. 2025 Apr 5;46:103780. doi: 10.1016/j.nicl.2025.103780.
3
The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization.
用于生物标志物分类的常见阿尔茨海默病研究本体(CADRO)。
Alzheimers Dement (N Y). 2025 Feb 11;11(1):e70050. doi: 10.1002/trc2.70050. eCollection 2025 Jan-Mar.
4
Comparison of Serum and Cerebrospinal Fluid Neurofilament Light Chain Concentrations Measured by Ella™ and Lumipulse™ in Patients with Cognitive Impairment.采用Ella™和Lumipulse™检测认知障碍患者血清和脑脊液神经丝轻链浓度的比较
Diagnostics (Basel). 2024 Oct 29;14(21):2408. doi: 10.3390/diagnostics14212408.